Ireland
--:--IST
Recruiting Observational

Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study

NCT06808542 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-02-04
Last updated
2025-02-25

Condition(s) studied

Pelvic Floor Disorders

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

This study aims to:

1. estimate the prevalence of pelvic floor dysfunction among female physiotherapy students at Cairo University.
2. identify potential risk factors that may be associated with pelvic floor dysfunction in this student population.
3. assess the level of awareness regarding pelvic floor health among female physiotherapy students at Cairo University.
4. explore how female physiotherapy students at Cairo University utilize available healthcare resources for managing pelvic floor-related concerns.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: * Virgin undergraduate physiotherapy students. * Their age will range from 18-25 years. Exclusion Criteria: * Neurological disorders or injuries that may affect pelvic floor function (e.g., fibromyalgia and multiple sclerosis). * Mental health or cognitive disorders that could affect data collection. * Females who have undergone any form of abdominal surgery prior to the time of the study. * Females with current use of medications that may affect pelvic floor function (e.g., anticholinergics, opioids, antidepressants).

Primary outcome measure(s)

  • Modified Australian pelvic floor questionnaire — 2 months
    It will be used to estimate the prevalence of pelvic floor disorders through assessing their bladder function, bowel function, and pelvic organ prolapse. This questionnaire will be administered electronically via online survey platforms.

Trial sites (1)

FacilityCityRegionStatus
Cairo University Giza Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06808542 on ClinicalTrials.gov ↗ ← All trials in Egypt